pc3 aggressive Search Results


aggressive metastatic pc3 cells  (ATCC)
99
ATCC aggressive metastatic pc3 cells
Aggressive Metastatic Pc3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aggressive metastatic pc3 cells/product/ATCC
Average 99 stars, based on 1 article reviews
aggressive metastatic pc3 cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
aggressive prostate cancer models  (ATCC)
99
ATCC aggressive prostate cancer models
Aggressive Prostate Cancer Models, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aggressive prostate cancer models/product/ATCC
Average 99 stars, based on 1 article reviews
aggressive prostate cancer models - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
aggressive pca models  (DSMZ)
93
DSMZ aggressive pca models
Figure 1. Antiproliferative and pro-apoptotic effects induced by azacitidine (5Aza-CR) at different concentrations in the presence or not of 10 ng/ml NGF. (A) <t>(PC3)</t> and (B) <t>(22rv1)</t> cells are subjected to the cytotoxic effects of different doses of azacitidine with or without NGF. (C) (PC3) and (D) (22rv1) cells undergo time-dependent apoptosis after treatment with a non-toxic concentration (0.5 µM) of azacitidine in combination with NGF. Data are representative of three independent replicates.
Aggressive Pca Models, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aggressive pca models/product/DSMZ
Average 93 stars, based on 1 article reviews
aggressive pca models - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Antiproliferative and pro-apoptotic effects induced by azacitidine (5Aza-CR) at different concentrations in the presence or not of 10 ng/ml NGF. (A) (PC3) and (B) (22rv1) cells are subjected to the cytotoxic effects of different doses of azacitidine with or without NGF. (C) (PC3) and (D) (22rv1) cells undergo time-dependent apoptosis after treatment with a non-toxic concentration (0.5 µM) of azacitidine in combination with NGF. Data are representative of three independent replicates.

Journal: Oncology reports

Article Title: Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.

doi: 10.3892/or.2016.4832

Figure Lengend Snippet: Figure 1. Antiproliferative and pro-apoptotic effects induced by azacitidine (5Aza-CR) at different concentrations in the presence or not of 10 ng/ml NGF. (A) (PC3) and (B) (22rv1) cells are subjected to the cytotoxic effects of different doses of azacitidine with or without NGF. (C) (PC3) and (D) (22rv1) cells undergo time-dependent apoptosis after treatment with a non-toxic concentration (0.5 µM) of azacitidine in combination with NGF. Data are representative of three independent replicates.

Article Snippet: Two aggressive PCa models (PC3 and 22rv1 cell lines) were obtained from the American Tissue Culture Collection (ATCC; Rockville, MD, uSA) and DSMZ (Braunschweig, Germany), respectively, and were grown as recommended.

Techniques: Concentration Assay

Figure 2. Western blot analyses show a time-dependent induction of p75NTR and AR, but not TrkA expression, after in vitro administration of 0.5 µM azacitidine (Aza-CR) in PC3 (A) and 22rv1. (C) Immunocytochemical expression of p75NTR and AR in 22rv1 cells. (D) PC3 and (E) 22rv1 cells were examined for expres- sion levels of downstream components proximal to p75NTR (TRADD, RIP, DR4, DR5 and TRAF2) after treatment with 0-5 µM azacitdine and 10 ng/ml NGF. (F) Immunohistochemical evaluation of p75NTR, TRADD and TRAL-R (DR4) in PC3 cell tumor-bearing nude mice treated or not with azacitidine (Vidaza 0.8 mg/kg/7 consecutive days). Each lane was loaded with 100 µg of proteins from the cell extracts obtained from the control and treated cells.

Journal: Oncology reports

Article Title: Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.

doi: 10.3892/or.2016.4832

Figure Lengend Snippet: Figure 2. Western blot analyses show a time-dependent induction of p75NTR and AR, but not TrkA expression, after in vitro administration of 0.5 µM azacitidine (Aza-CR) in PC3 (A) and 22rv1. (C) Immunocytochemical expression of p75NTR and AR in 22rv1 cells. (D) PC3 and (E) 22rv1 cells were examined for expres- sion levels of downstream components proximal to p75NTR (TRADD, RIP, DR4, DR5 and TRAF2) after treatment with 0-5 µM azacitdine and 10 ng/ml NGF. (F) Immunohistochemical evaluation of p75NTR, TRADD and TRAL-R (DR4) in PC3 cell tumor-bearing nude mice treated or not with azacitidine (Vidaza 0.8 mg/kg/7 consecutive days). Each lane was loaded with 100 µg of proteins from the cell extracts obtained from the control and treated cells.

Article Snippet: Two aggressive PCa models (PC3 and 22rv1 cell lines) were obtained from the American Tissue Culture Collection (ATCC; Rockville, MD, uSA) and DSMZ (Braunschweig, Germany), respectively, and were grown as recommended.

Techniques: Western Blot, Expressing, In Vitro, Immunohistochemical staining, Control